LEO 29102 Cream Vehicle

DRUG2 trials

Sponsors

LEO Pharma

Conditions

Atopic DermatitisPsoriasis Vulgaris

Phase 1

Safety, Tolerability and Pharmacokinetics of LEO 29102 Cream in Atopic Dermatitis.

TerminatedNCT01447758

LEO PharmaAtopic Dermatitis

Start: 2011-09-30End: 2013-03-31Updated: 2025-02-24

Phase 2

A Psoriasis Plaque Test With LEO 29102 Cream and Its Combination Products

CompletedNCT00875277

LEO PharmaPsoriasis Vulgaris

Start: 2009-04-30End: 2009-07-31Updated: 2025-03-12